News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSense Technologies' Novel Diagnostic Testing Platform for Rapid Drug Susceptibility Presented at the National Foundation for Infectious Diseases 2010 Annual Conference



3/18/2010 10:23:35 AM

WOBURN, Mass.--(BUSINESS WIRE)--BioSense Technologies, a pioneer in the development of diagnostic systems for rapid drug susceptibility testing, announced today that it presented key scientific findings at the National Foundation for Infection Disease 2010 Annual Conference on Antimicrobial Resistance, held in Bethesda, MD in early February. The Company presented compelling scientific data in a poster presentation (www.biosensetech.com/publications.htm) demonstrating that its Z-Senseā„¢ Differential Impedance Sensing diagnostic system rapidly and accurately identified the drug susceptibility of bacteria, yeast, and cancer cells exposed to therapeutic agents in near real-time. The growing resistance of bacteria to antibiotics combined with the shortage of available new drugs threatens the ability to cure infections that were previously treatable.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES